NexGard Combo (2.5 - 7.5 kg)
Active substance
ATC code
Species
Cats.
Indications
For cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. The veterinary medicinal product is exclusively indicated when all three groups are targeted at the same time.
Ectoparasites
- Treatment of infestations by fleas (Ctenocephalides felis). One treatment provides immediate and persistent flea killing activity for one month.
- The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
- Treatment of infestations by ticks. One treatment provides immediate and persistent tick killing activity against Ixodes scapularis for one month and against Ixodes ricinus for five weeks.
- Treatment of infestations by ear mites (Otodectes cynotis).
- Treatment of Notoedric mange (caused by Notoedres cati).
Gastro-intestinal cestodes
- Treatment of infections with tapeworms (Dipylidium caninum, Taenia taeniaeformis, Echinococcus multilocularis, Joyeuxiella pasqualei and Joyeuxiella fuhrmanni).
Nematodes
Gastro-intestinal nematodes
- Treatment of infections with gastrointestinal nematodes (L3, L4 larvae and adults of Toxocara cati, L4 larvae and adults of Ancylostoma tubaeforme and Ancylostoma ceylanicum, and adult forms of Toxascaris leonina and Ancylostoma braziliense).
Cardio-pulmonary nematodes
- Prevention of heartworm disease (Dirofilaria immitis) for one month.
- Treatment of infections with feline lungworms (L4 larvae and adults of Troglostrongylus brevior, L3, L4 larvae and adults of Aelurostrongylus abstrusus).
Vesical nematodes
- Treatment of infections with vesical worms (Capillaria plica).
Dose to be administered and administration route
Spot-on use.
Dosage:
The recommended minimum doses are 1.44 mg esafoxolaner, 0.48 mg eprinomectin and 10 mg praziquantel per kg bodyweight.
Select the appropriate applicator size for the weight of the cat.
|
Cat weight |
Volume of unit dose (ml) |
Esafoxolaner (mg) |
Eprinomectin (mg) |
Praziquantel (mg) |
|
0.8-< 2.5 kg |
0.3 |
3.60 |
1.20 |
24.90 |
|
2.5-<7.5 kg |
0.9 |
10.80 |
3.60 |
74.70 |
|
≥7.5 kg |
appropriate combination of applicators |
|||
Method of administration:
1. Use scissors to cut the blister along the dotted line.
2. Then pull the lid away.
3. Remove the applicator from the package and hold it upright. Pull back the plunger slightly
4. Twist and pull off the cap.
5. Part the hair on the midline of the neck, between the base of the skull and the shoulder blades until the skin is visible. Place the tip of the applicator on the skin and apply the entire content directly onto the skin in one spot. The product should be applied to dry skin on an area where the cat cannot lick it off. In long hair breeds, special attention should be paid to apply the product onto the skin, and not on the hair to ensure optimal efficacy.
6. Wash your hands after use.
Treatment schedule:
For the treatment of infestations with fleas and/or ticks and/or mites, and the concurrent treatment of gastrointestinal and/or pulmonary, and/or vesical nematodes, and cestodes, a single dose of the product should be applied. The need for and frequency of re-treatment(s) should be in accordance with the advice of the prescribing veterinarian and should take into account the local epidemiological situation and the animal’s lifestyle (e.g. outdoors access). See also section 4.5.
Areas which are not endemic for heartworm:
Cats not exposed to a permanent risk of heartworm infection should be treated according to a schedule prescribed by the veterinarian and adapted to each individual situation of re-infection/-infestation with parasites. Otherwise, a narrow spectrum product should be used to ensure sustainable treatment against relevant parasites.
Heartworm endemic areas:
Cats living in heartworm endemic areas and recognised as hunters might be treated at monthly intervals to ensure both appropriate heartworm disease prevention and treatment of potential re- infection with cestodes. Otherwise, a narrow spectrum product should be used for further treatment. Prevention of heartworm disease by killing Dirofilaria immitis larvae should start within 1 month after the first expected exposure to mosquitoes and should be continued until at least 1 month after the last exposure to mosquitoes.
Lungworm treatment:
No or little effect on the L1 larvae release of A. abstrusus in the faeces can be expected within approximately 2 weeks after treatment due to the transit period of L1 larvae from the lungs through the digestive tract. Any faecal larval count to control effectiveness of treatment (and the decision if a second treatment with a narrow spectrum product is necessary) should, therefore, only be made two weeks after treatment at the earliest.
Ear mites:
For ear mites, seek further veterinary examination 4 weeks after treatment to determine whether an additional treatment with a narrow spectrum product is necessary.
Adverse reactions
Hypersalivation, diarrhoea, transient skin reactions at the application site (alopecia, pruritus), anorexia, lethargy and emesis were uncommonly observed in clinical trials shortly after administration. They are mostly mild reactions, of short duration and selflimiting.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 04491/5001 |
| EAN | 4028691561996 |
